Oncornavirus vaccines and feline alpha-type interferon

Details Oncornavirus vaccines and feline alpha-type interferon Oncornavirus vaccines and feline alpha-type interferon

1986-07-03

1989-08-29

Hazel, Blondel

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

Inactivation or attenuation; producing viral subunits

424 89, 424 93, C12N 706, A61K 3921

Patent

active

048617202

ABSTRACT:
Retroviral vaccines are provided comprising incompetent retroviruses containing defective RNA produced by growing viral transformed cells in the presence of interferon. The resulting defective viruses by themselves or in combination with interferon can be used as vaccines for immunizing viral sensitive hosts against infection. A novel feline interferon is produced in culture with cells infected with the defective non-infectious retroviruses.

REFERENCES:
patent: 4086134 (1978-04-01), Jarrett et al.
patent: 4264587 (1981-04-01), Pedersen
patent: 4699785 (1987-10-01), Pedersen
Chemical Abstracts, vol. 103, Abstract No. 140019h, 1983.
Chemical Abstracts, vol. 99, Abstract No. 20761w, 1983.
Chemical Abstracts, vol. 98, Abstract No. 158909m, 1983.
Chemical Abstracts, vol. 77, Abstract No. 86507v, 1972.
Chemical Abstracts, vol. 99, Abstract No. 156594b, 1983.

Affiliated with

Also associated with

Rating

Oncornavirus vaccines and feline alpha-type interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oncornavirus vaccines and feline alpha-type interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oncornavirus vaccines and feline alpha-type interferon will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2237994